Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
ENDOLOGIX INC /DE/
| Metric | ENDOLOGIX INC /DE/ Healthcare |
|---|---|
| Quality Score | 23 / 100 |
| Revenue (latest) | $36M |
| Net income (latest) | −$22M |
| Operating margin | −119.5% |
| Net margin | −61.9% |
| Return on equity | −34.5% |
| Return on assets | −7.2% |
| Return on capital (ROCE) | −16.9% |
| Debt / equity | 3.81× |
| Revenue growth (YoY) | −15.8% |
| Altman Z″ (distress) | -6.90 |
| Accruals / assets | 2.5% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.